查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1829767

2025年全球病人自控注射器市场报告

Patient Controlled Injectors Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，患者自控注射器市场快速扩张，市场规模从2024年的45.1亿美元成长至2025年的50.8亿美元，复合年增长率达12.5%。预测期内的增长归因于居家医疗的增长、医疗基础设施的扩展、糖尿病患者数量的增加、感染疾病病率的上升以及对个性化医疗的日益关注。

预计未来几年患者自控注射器市场将快速成长，到2029年将达到79.4亿美元，复合年增长率为11.8%。预测期内的成长归因于人口老化加剧、慢性呼吸系统疾病盛行率上升、慢性病盛行率上升、癌症盛行率上升以及自体免疫疾病盛行率上升。预测期内的主要趋势包括技术进步、人工智慧整合、远端医疗、远端监控、携带式和可穿戴设备的进步以及对微创手术的重视。

患者控制注射器是医疗设备，旨在让患者自行给药，精确控制剂量和时间，易于使用，并允许患者独立管理治疗，通常在家中。

患者控制注射器的主要类型包括电子穿戴式註射器、机械穿戴式註射器和输液帮浦。电子注射器能够实现自动化和精准的药物输送，并且通常具备追踪和监控使用情况的连接功能，从而为患者提供更高的便利性和数据主导的洞察。这些设备用于治疗癌症、自体免疫疾病和血液疾病等疾病，并透过医院药局、零售药局和通讯销售管道销售。

2025年春季美国大幅提高关税及其引发的贸易摩擦对医疗设备产业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要重新认证医疗设备，导致市场进入延迟。为此，企业正在透过双重采购关键零件、增加标准产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供病人自控注射器市场统计数据，例如全球市场规模、区域份额、病人自控注射器市场份额的竞争对手、详细的病人自控注射器市场细分、市场趋势以及病人自控注射器行业的商机，为您提供在病人自控注射器行业取得成功所需的数据。本病人自控注射器研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的全面观点。

我们预测未来五年该市场将成长11.8%，较先前预测略有下降0.9%。下降主要源自于美国与其他国家之间关税的影响。这种影响可能会直接影响美国，导致精密微流体帮浦和抛弃式墨盒的供应延迟，这些产品严重依赖从爱尔兰和台湾进口，从而扰乱疼痛管理疗法。由于互惠关税以及不断升级的贸易紧张局势和限制对全球经济和贸易造成的负面影响，这种影响也将更加广泛。

预计未来几年慢性病盛行率的上升将推动患者控制注射器市场的成长。人口老化、肥胖症流行、社会经济经济状况和环境因素等因素正在推动持续时间超过三个月且往往会随着时间的推移而恶化的慢性病的增加。患者控制注射器使患者能够根据治疗计划准确、方便地自行服药。例如，2023 年 1 月，美国国家生物技术资讯中心 (NCBI) 预测，患有一种或多种慢性病的 50 岁及以上人数将从 2020 年的 7152 万人增加 99.5% 到 2050 年的 1.4266 亿。因此，预计慢性病盛行率的上升将推动患者控制注射器市场向前发展。

为了更好地满足客户需求，该市场的主要企业正在透过开发即用型注射器等先进产品进行创新。即用型注射器预先填充并灭菌，并配备精确剂量的药物，无需手动准备，并降低了污染和给药错误的风险。例如，Ypsomed AG 于 2022 年 10 月推出了专为 1.5 至 5.5 毫升液体药物设计的新型自动注射器平台。本设备采用符合人体工学的使用者友善设计，确保患者在註射过程中的舒适度，并配备先进的安全机制，防止针刺伤。此外，视觉和听觉回馈可确认药物传递是否成功，且其与各种黏度药物的兼容性使其适用于各种治疗应用。

2023年4月，LTS Lohmann Therapie-Systeme AG 收购了 Eitan Medical 旗下的 Sorrel 穿戴式註射器业务，扩大了其药物输送产品组合。此次收购增强了 LTS 在先进穿戴式註射技术领域的能力，并进一步巩固了该公司在患者控制注射器市场的地位。 Eitan Medical Ltd. 是一家总部位于以色列的公司，致力于开发创新药物输送设备，包括病患控制注射器。

患者自控注射器市场包括预填充式注射器、自动注射器、内建注射器和无针注射器的销售。该市场的价值是指“出厂价”，即商品製造商或生产商销售给其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接销售给最终客户的价值。该市场中的商品价值还包括商品製造商提供的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球病患自控注射器：PESTEL 分析（政治、社会、科技、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球病患自控注射器市场：成长率分析
  • 全球病患自控注射器市场表现：规模与成长，2019-2024
  • 全球病患自控注射器市场预测：规模与成长，2024-2029年，2034年
  • 全球病患自控注射器：总目标市场（TAM）

第六章 市场细分

  • 全球病患自控注射器市场：依产品、实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 电子穿戴式註射器
  • 机械式可穿戴注射器
  • 点滴帮浦
  • 全球病患自控注射器市场：依应用、实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 癌症治疗
  • 自体免疫治疗
  • 血液疾病的治疗
  • 其他应用
  • 全球病患自控注射器市场：依通路、实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 医院药房
  • 零售药局
  • 通讯药房
  • 全球病患控制注射器市场：按类型细分：穿戴式电子注射器，实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 预填充电子穿戴式註射器
  • 可程式设计电子穿戴式註射器
  • 智慧电子穿戴式註射器
  • 充电式穿戴式电子注射器
  • 支援蓝牙的可穿戴电子注射器
  • 免洗电子穿戴式註射器
  • 全球病患控制注射器市场：依机械穿戴式註射器类型细分，实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 弹簧式机械穿戴式註射器
  • 穿戴式活塞式机械注射器
  • 自动注射器（机械）
  • 手动机械穿戴式註射器
  • 免洗式可穿戴机械注射器
  • 全球病患控制注射器市场：依输液帮浦类型细分，实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 一次性输液泵
  • 可程式设计输液泵
  • 胰岛素输注泵
  • 注射输液帮浦
  • 携带式输液泵
  • 大容量输液泵
  • 植入式输液泵

第七章 区域和国家分析

  • 全球病患自控注射器市场：按地区、实际结果和预测，2019-2024 年、2024-2029 年、2034 年
  • 全球病人自控注射器市场：国家、现况及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 病患控制注射器市场：竞争格局
  • 病患控制注射器市场：公司简介
    • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • West Pharmaceutical Services Overview, Products and Services, Strategy and Financial Analysis
    • SCHOTT AG Overview, Products and Services, Strategy and Financial Analysis
    • Gerresheimer AG Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Phillips-Medisize
  • Vetter Pharma-Fertigung GmbH & Co. KG
  • Stevanato Group
  • Ypsomed AG
  • Nemera
  • B. Braun Melsungen AG
  • Elcam Medical
  • Owen Mumford
  • Bespak
  • Unilife Corporation
  • Crossject
  • SHL Group
  • AptarGroup Inc.
  • Credence MedSystems
  • Weibel CDS AG

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年病患自控注射器市场：提供新机会的国家
  • 2029年病患自控注射器市场：细分市场带来新机会
  • 2029年病患自控注射器市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r30899u

Patient-controlled injectors are medical devices designed to empower patients to self-administer medication with precise control over dosage and timing. They are user-friendly, facilitating independent management of treatment, typically in home settings.

The primary types of patient-controlled injectors include electronic wearable injectors, mechanical wearable injectors, and infusion pumps. Electronic versions enable automated and precise medication delivery, often equipped with connectivity features for tracking and monitoring usage. This enhances convenience and provides data-driven insights for patients. These devices find applications in treatments such as cancer, autoimmune disorders, and blood disorders, distributed through hospital pharmacies, retail pharmacies, and mail-order channels.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The patient-controlled injectors market research report is one of a series of new reports from The Business Research Company that provides patient-controlled injectors market statistics, including patient-controlled injectors industry global market size, regional shares, competitors with a patient-controlled injectors market share, detailed patient-controlled injectors market segments, market trends, and opportunities, and any further data you may need to thrive in the patient-controlled injectors industry. This patient-controlled injectors research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The patient controlled injectors market size has grown rapidly in recent years. It will grow from $4.51 billion in 2024 to $5.08 billion in 2025 at a compound annual growth rate (CAGR) of 12.5%. The growth in the historic period can be attributed to growth in home healthcare, expansion of healthcare infrastructure, increasing cases of diabetes, increased prevalence of infectious diseases, and increasing focus on personalized medicine.

The patient controlled injectors market size is expected to see rapid growth in the next few years. It will grow to $7.94 billion in 2029 at a compound annual growth rate (CAGR) of 11.8%. The growth in the forecast period can be attributed to a rising aging population, rising incidence of chronic respiratory diseases, increasing prevalence of chronic diseases, increasing cancer cases, and increasing autoimmune disorders prevalence. Major trends in the forecast period include technological advancements, integration of artificial intelligence, telemedicine, remote monitoring, advancements in portable and wearable devices, and focus on minimally invasive procedures.

The forecast of 11.8% growth over the next five years reflects a modest reduction of 0.9% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply delays for precision microfluidic pumps and disposable cartridges, heavily reliant on imports from Ireland and Taiwan, disrupting pain management therapies.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising prevalence of chronic diseases is poised to drive the growth of the patient-controlled injectors market in the coming years. Chronic illnesses, lasting three months or more and often worsening over time, are increasing due to factors such as an aging population, the obesity epidemic, socioeconomic conditions, and environmental factors. Patient-controlled injectors enable individuals to self-administer medications accurately, conveniently, and according to their treatment schedules. For example, the National Center for Biotechnology Information (NCBI) projected in January 2023 that the number of individuals aged 50 and older with one or more chronic conditions will rise by 99.5% by 2050, from 71.52 million in 2020 to 142.66 million. Therefore, the growing prevalence of chronic diseases is expected to propel the patient-controlled injectors market forward.

Leading companies in this market are innovating by developing advanced products such as ready-to-use syringes to better meet customer needs. Ready-to-use syringes come prefilled and sterilized with a precise dose of medication, eliminating the need for manual preparation and reducing risks of contamination and dosing errors. For instance, in October 2022, Ypsomed AG introduced a new autoinjector platform tailored for liquid pharmaceuticals ranging from 1.5 to 5.5 ml. This device features ergonomic design for ease of use, ensuring patient comfort during injections, along with advanced safety mechanisms to prevent accidental needle sticks. It provides visual and audible feedback to confirm successful medication delivery and is versatile for various therapeutic applications due to its compatibility with different viscosities.

In April 2023, LTS Lohmann Therapie-Systeme AG expanded its drug delivery portfolio by acquiring the sorrel wearable injection device business from Eitan Medical. This acquisition enhances LTS's capabilities in advanced wearable injection technologies, further solidifying its presence in the patient-controlled injectors market. Eitan Medical Ltd. is an Israel-based company that develops innovative drug delivery devices, including patient-controlled injectors.

Major companies operating in the patient controlled injectors market are Medtronic plc, Becton Dickinson and Company, West Pharmaceutical Services, SCHOTT AG, Gerresheimer AG, Phillips-Medisize, Vetter Pharma-Fertigung GmbH & Co. KG, Stevanato Group, Ypsomed AG, Nemera, B. Braun Melsungen AG, Elcam Medical, Owen Mumford, Bespak, Unilife Corporation, Crossject, SHL Group, AptarGroup Inc., Credence MedSystems, Weibel CDS AG, Sorrel Medical

North America was the largest region in the patient controlled injectors market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the patient controlled injectors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the patient controlled injectors market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The patient-controlled injectors market consists of sales of prefilled syringes, auto-injectors, on-body injectors, and needle-free injectors. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Patient Controlled Injectors Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on patient controlled injectors market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for patient controlled injectors ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The patient controlled injectors market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Electronic Wearable Injector; Mechanical Wearable Injector; Infusion Pumps
  • 2) By Application: Cancer Treatment; Auto-Immune Treatment; Blood Disorder Treatment; Other Application
  • 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Mail Order Pharmacies
  • Subsegments:
  • 1) By Electronic Wearable Injector: Pre-Filled Electronic Wearable Injectors; Programmable Electronic Wearable Injectors; Smart Electronic Wearable Injectors; Rechargeable Electronic Wearable Injectors; Bluetooth-Enabled Electronic Wearable Injectors; Disposable Electronic Wearable Injectors
  • 2) By Mechanical Wearable Injector: Spring-Loaded Mechanical Wearable Injectors; Piston-Based Mechanical Wearable Injectors; Auto-Injectors (Mechanical); Manual Mechanical Wearable Injectors; Disposable Mechanical Wearable Injectors
  • 3) By Infusion Pumps: Disposable Infusion Pumps; Programmable Infusion Pumps; Insulin Infusion Pumps; Syringe Infusion Pumps; Ambulatory Infusion Pumps; Large Volume Infusion Pumps; Implantable Infusion Pumps
  • Companies Mentioned: Medtronic plc; Becton Dickinson and Company; West Pharmaceutical Services; SCHOTT AG; Gerresheimer AG; Phillips-Medisize; Vetter Pharma-Fertigung GmbH & Co. KG; Stevanato Group; Ypsomed AG; Nemera; B. Braun Melsungen AG; Elcam Medical; Owen Mumford; Bespak; Unilife Corporation; Crossject; SHL Group; AptarGroup Inc.; Credence MedSystems; Weibel CDS AG; Sorrel Medical
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Patient Controlled Injectors Market Characteristics

3. Patient Controlled Injectors Market Trends And Strategies

4. Patient Controlled Injectors Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Patient Controlled Injectors Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Patient Controlled Injectors PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Patient Controlled Injectors Market Growth Rate Analysis
  • 5.4. Global Patient Controlled Injectors Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Patient Controlled Injectors Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Patient Controlled Injectors Total Addressable Market (TAM)

6. Patient Controlled Injectors Market Segmentation

  • 6.1. Global Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Electronic Wearable Injector
  • Mechanical Wearable Injector
  • Infusion Pumps
  • 6.2. Global Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cancer Treatment
  • Auto-Immune Treatment
  • Blood Disorder Treatment
  • Other Application
  • 6.3. Global Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies
  • Mail Order Pharmacies
  • 6.4. Global Patient Controlled Injectors Market, Sub-Segmentation Of Electronic Wearable Injector, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pre-Filled Electronic Wearable Injectors
  • Programmable Electronic Wearable Injectors
  • Smart Electronic Wearable Injectors
  • Rechargeable Electronic Wearable Injectors
  • Bluetooth-Enabled Electronic Wearable Injectors
  • Disposable Electronic Wearable Injectors
  • 6.5. Global Patient Controlled Injectors Market, Sub-Segmentation Of Mechanical Wearable Injector, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Spring-Loaded Mechanical Wearable Injectors
  • Piston-Based Mechanical Wearable Injectors
  • Auto-Injectors (Mechanical)
  • Manual Mechanical Wearable Injectors
  • Disposable Mechanical Wearable Injectors
  • 6.6. Global Patient Controlled Injectors Market, Sub-Segmentation Of Infusion Pumps, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Disposable Infusion Pumps
  • Programmable Infusion Pumps
  • Insulin Infusion Pumps
  • Syringe Infusion Pumps
  • Ambulatory Infusion Pumps
  • Large Volume Infusion Pumps
  • Implantable Infusion Pumps

7. Patient Controlled Injectors Market Regional And Country Analysis

  • 7.1. Global Patient Controlled Injectors Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Patient Controlled Injectors Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Patient Controlled Injectors Market

  • 8.1. Asia-Pacific Patient Controlled Injectors Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Patient Controlled Injectors Market

  • 9.1. China Patient Controlled Injectors Market Overview
  • 9.2. China Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Patient Controlled Injectors Market

  • 10.1. India Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Patient Controlled Injectors Market

  • 11.1. Japan Patient Controlled Injectors Market Overview
  • 11.2. Japan Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Patient Controlled Injectors Market

  • 12.1. Australia Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Patient Controlled Injectors Market

  • 13.1. Indonesia Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Patient Controlled Injectors Market

  • 14.1. South Korea Patient Controlled Injectors Market Overview
  • 14.2. South Korea Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Patient Controlled Injectors Market

  • 15.1. Western Europe Patient Controlled Injectors Market Overview
  • 15.2. Western Europe Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Patient Controlled Injectors Market

  • 16.1. UK Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Patient Controlled Injectors Market

  • 17.1. Germany Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Patient Controlled Injectors Market

  • 18.1. France Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Patient Controlled Injectors Market

  • 19.1. Italy Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Patient Controlled Injectors Market

  • 20.1. Spain Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Patient Controlled Injectors Market

  • 21.1. Eastern Europe Patient Controlled Injectors Market Overview
  • 21.2. Eastern Europe Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Patient Controlled Injectors Market

  • 22.1. Russia Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Patient Controlled Injectors Market

  • 23.1. North America Patient Controlled Injectors Market Overview
  • 23.2. North America Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Patient Controlled Injectors Market

  • 24.1. USA Patient Controlled Injectors Market Overview
  • 24.2. USA Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Patient Controlled Injectors Market

  • 25.1. Canada Patient Controlled Injectors Market Overview
  • 25.2. Canada Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Patient Controlled Injectors Market

  • 26.1. South America Patient Controlled Injectors Market Overview
  • 26.2. South America Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Patient Controlled Injectors Market

  • 27.1. Brazil Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Patient Controlled Injectors Market

  • 28.1. Middle East Patient Controlled Injectors Market Overview
  • 28.2. Middle East Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Patient Controlled Injectors Market

  • 29.1. Africa Patient Controlled Injectors Market Overview
  • 29.2. Africa Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Patient Controlled Injectors Market Competitive Landscape And Company Profiles

  • 30.1. Patient Controlled Injectors Market Competitive Landscape
  • 30.2. Patient Controlled Injectors Market Company Profiles
    • 30.2.1. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. West Pharmaceutical Services Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. SCHOTT AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Gerresheimer AG Overview, Products and Services, Strategy and Financial Analysis

31. Patient Controlled Injectors Market Other Major And Innovative Companies

  • 31.1. Phillips-Medisize
  • 31.2. Vetter Pharma-Fertigung GmbH & Co. KG
  • 31.3. Stevanato Group
  • 31.4. Ypsomed AG
  • 31.5. Nemera
  • 31.6. B. Braun Melsungen AG
  • 31.7. Elcam Medical
  • 31.8. Owen Mumford
  • 31.9. Bespak
  • 31.10. Unilife Corporation
  • 31.11. Crossject
  • 31.12. SHL Group
  • 31.13. AptarGroup Inc.
  • 31.14. Credence MedSystems
  • 31.15. Weibel CDS AG

32. Global Patient Controlled Injectors Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Patient Controlled Injectors Market

34. Recent Developments In The Patient Controlled Injectors Market

35. Patient Controlled Injectors Market High Potential Countries, Segments and Strategies

  • 35.1 Patient Controlled Injectors Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Patient Controlled Injectors Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Patient Controlled Injectors Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer